Byrne Wallace Shields LLP‘s intellectual property team assists in a range of contentious and non-contentious IP mandates, including brand and design protection. Considered a go-to for clients in the life sciences sector, Colin Sainsbury leads the non-contentious IP offering and regularly drafts and negotiates licensing, supply and service agreements. Jane O’Grady, who joined as part of the merger in 2025, is a strong adviser on the IP aspects of acquisitions and sales, and the protection, commercialisation and infringement of IP more broadly.
Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘Personal attention to detail and responsiveness makes this team unique.’
  • ‘Strong teamwork and culture. Good coordination amongst partners in terms of responding to client queries.’
  • ‘Jane O'Grady is clearly a subject matter expert in the Intellectual Property domain and all my questions were comprehensively answered. Jane also adopts a commercial pragmatic approach which is especially helpful.’
  • 'Colin Sainsbury is a long standing and well renowned professional.'
  • 'Excellent to deal with good communication and easy to understand.'

Key clients

  • Starbucks Corporation
  • Headstuff Podcasts
  • Corpay
  • Suil Vision
  • UltraGreen.ai/Renew Pharma
  • Neuromod Devices Limited
  • Priothera Limited
  • Xeolas Pharmaceuticals Limited
  • Versono Medical Limited
  • Warburton Technology
  • European Circular Bioeconomy Fund
  • Q3 Medical Devices Limited

Work highlights

Advising MVM Partners (the lead investor) and OrbiMed in relation to the announced $80m Series B financing of ProVerum Limited
Advising StatisticaMedica on the negotiation and successful conclusion of a number of complex master services agreements with multinational life sciences companies.
Practice head

Colin Sainsbury

Other key lawyers

Jane O’Grady; Victor Timon; Laura Greene